Virbac
€308.00Change from previous close: +0.49%Absolute change: +€1.50
At a glance
- Revenue growth
- +4.82%
- 2025 vs 2024
- Net income growth
- +3.85%
- 2025 vs 2024
- Net margin
- 10.3%
- 2024: 10.4%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 1,465 | 1,397 | 1,247 | 1,216 | — |
| Cost of revenue | 490 | 460 | 437 | 426 | — |
| Gross profit | 975 | 938 | 810 | 790 | — |
| Selling, general and administrative | — | — | — | — | 203 |
| Operating income | 230 | 228 | 186 | 183 | — |
| EBIT | 226 | 219 | 183 | 180 | — |
| EBITDA | 287 | 276 | 231 | 229 | — |
| Interest expense | 8.8 | 11.1 | 8.9 | 3.7 | — |
| Pre-tax income | 218 | 208 | 174 | 176 | — |
| Income tax | 67.2 | 62.5 | 53.5 | 55.7 | — |
| Net income | 151 | 145 | 121 | 122 | — |
| Net income to common shareholders | 151 | 145 | 121 | 122 | — |
| Basic EPS | 18.01 | 17.35 | 14.40 | 14.43 | — |
| Diluted EPS | 18.00 | 17.34 | 14.38 | 14.42 | — |
| Average shares (basic) | 8.4 | 8.4 | 8.4 | 8.4 | — |
| Average shares (diluted) | 8.4 | 8.4 | 8.4 | 8.5 | — |